Complex encephalopathy arising from the combination of opioids and gabapentin
- PMID: 31005866
- PMCID: PMC6506108
- DOI: 10.1136/bcr-2018-228354
Complex encephalopathy arising from the combination of opioids and gabapentin
Abstract
The interactions between opioids and gabapentin are more clinically relevant than ever. Prescriptions dispensed for gabapentin increased from 39 million in 2012 to 64 million in 2018 in the USA and are ever increasing. Authors present a challenging case of these interactions. A 58-year-old man presented to the emergency department with acute respiratory failure and altered mental status. He was on high dose opioids and gabapentin as prescription medications. Despite full intensive care support and resolution of his respiratory failure with non-invasive positive pressure ventilation, the patient did not regained consciousness. After ruling out other causes, the diagnosis of gabapentin withdrawal was considered. Gabapentin was administered by a nasogastric tube that quickly resulted in a reversal of his symptoms. We concluded that severe gabapentin withdrawal should be considered in patients on higher doses of gabapentin when it is stopped abruptly. In such patients, gabapentin should be replaced. As most patients are unable to swallow in this situation and intravenous formulation is not available, nasogastric tube can be used for replacement.
Keywords: adult intensive care; drug interactions; drugs and medicines; drugs: cns (not psychiatric).
© BMJ Publishing Group Limited 2019. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: None declared.
Similar articles
-
Complex encephalopathy arising from the combination of opioids and gabapentin.Drug Ther Bull. 2019 Aug;57(8):125-127. doi: 10.1136/dtb.2019.228354rep. Drug Ther Bull. 2019. PMID: 31345958
-
Gabapentin as add-on to morphine for severe neuropathic or mixed pain in children from age 3 months to 18 years - evaluation of the safety, pharmacokinetics, and efficacy of a new gabapentin liquid formulation: study protocol for a randomized controlled trial.Trials. 2019 Jan 15;20(1):49. doi: 10.1186/s13063-018-3169-3. Trials. 2019. PMID: 30646965 Free PMC article.
-
A clinical trial to determine if corelease of morphine and naltrexone from crushed extended-release capsules induces withdrawal in opioid-dependent patients: a descriptive analysis of six patients.J Opioid Manag. 2013 Mar-Apr;9(2):139-50. doi: 10.5055/jom.2013.0155. J Opioid Manag. 2013. PMID: 23709323 Clinical Trial.
-
Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).Pain Pract. 2008 Jul-Aug;8(4):287-313. doi: 10.1111/j.1533-2500.2008.00204.x. Epub 2008 May 23. Pain Pract. 2008. PMID: 18503626
-
Acute opioid withdrawal precipitated by ingestion of crushed embeda (morphine extended release with sequestered naltrexone): case report and the focused review of the literature.J Opioid Manag. 2010 Jul-Aug;6(4):300-3. doi: 10.5055/jom.2010.0028. J Opioid Manag. 2010. PMID: 20862910 Review.
References
-
- Gomes T, Juurlink DN, Antoniou T, et al. . Opioids and the risk of opioid-related death: a population-based nested case–control study. http://journals.plos.org/plosmedicine/article?id= - PMC - PubMed
-
- United states food and drug administration (Internet). Database on gabapentin. http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/020235s041,0208....
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials